OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Showing 7 citing articles:
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Adoptive T Cell Therapy Targeting MAGE-A4
Kapil Chandora, Akshay Chandora, Anwaar Saeed, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 413-413
Open Access
Kapil Chandora, Akshay Chandora, Anwaar Saeed, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 413-413
Open Access
Gold Nanoparticles Synthesized with Triple-Negative Breast Cancer Cell Lysate Enhance Antitumoral Immunity: A Novel Synthesis Method
Raúl Rangel‐López, Moisés Ármides Franco-Molina, Cristina Rodríguez‐Padilla, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 330-330
Open Access
Raúl Rangel‐López, Moisés Ármides Franco-Molina, Cristina Rodríguez‐Padilla, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 330-330
Open Access
Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies
Qiujun Zhou, Xiaoliang Jin, Ying Zhao, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 13, pp. 1186-1193
Open Access | Times Cited: 1
Qiujun Zhou, Xiaoliang Jin, Ying Zhao, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 13, pp. 1186-1193
Open Access | Times Cited: 1
Engineered immune cell-based therapeutics for female reproductive tract cancers: Advances and future prospects
Nazim Nazeer, Rimpa Manna, S.K. Shukla, et al.
Journal of Reproductive Healthcare and Medicine (2024) Vol. 5, pp. 14-14
Closed Access | Times Cited: 1
Nazim Nazeer, Rimpa Manna, S.K. Shukla, et al.
Journal of Reproductive Healthcare and Medicine (2024) Vol. 5, pp. 14-14
Closed Access | Times Cited: 1
Immunoengineering a Future of Molecular, Material, and Cellular Therapeutics
Jeffrey A. Hubbell
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 167-168
Closed Access
Jeffrey A. Hubbell
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 167-168
Closed Access
Exploring structure-directed immunogenic cytotoxicity of arginine-rich peptides for cytolysis-induced immunotherapy of cancer
Liu Huang, Ang Li, Han-jie Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 117984-117984
Closed Access
Liu Huang, Ang Li, Han-jie Liu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 117984-117984
Closed Access
